Extended pharmacodynamic responses observed upon PROTAC-mediated degradation of RIPK2

Alina Mares(GlaxoSmithKline (United Kingdom)), John D. Harling(Age UK)

Communications Biology

March 20, 2020

10.1038/s42003-020-0868-6

Cited by 220

Related Papers

No related papers found

Powered by citation graph analysis